Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted expedited approval to orforglipron…[#item_full_content]
Dimon: US Confronting Greatest Geopolitical Risks Since WWII
Aprile 2, 2026
The United States is confronting the most simultaneous risks in more than 80 years, facing a convergence of political tensions, financial vulnerability, and technological disruption,
